Ventilator Associated Pneumonia Vap clinical trials

Explore recruiting ventilator associated pneumonia vap clinical trials.

Recruiting ventilator associated pneumonia vap studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Ventilator Associated Pneumonia Vap trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A multicentre, double-blind, randomized controlled trial of inhaled amikacin versus placebo in critically ill patients with ventilator-associated tracheobronchitis (AMIVAT)

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Randomized, Parallel, Open-Label, Phase 1/2a Study to Assess the Safety and Tolerability of Multiple Doses of the Bacteriophage Cocktail TP-122 (Component TP-122A), for the Treatment of Ventilator-Associated Pneumonia

Portugal, Netherlands

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

C3601010: A Phase 2A, 2-Part, Open-Label, Non-Randomized, Multicenter, Single and Multiple Dose Trial to Evaluate Pharmacokinetics, Safety and Tolerability of Aztreonam and Avibactam ± Metronidazole in Neonates and Infants From Birth to Less Than 9 Months of Age With Suspected or Confirmed Infections Due to Gram-Negative Pathogens Requiring Intravenous Antibiotic Treatment

Slovakia, Greece, Bulgaria, Italy, Hungary, Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Ventilator Associated Pneumonia Vap trials by city

Ventilator Associated Pneumonia Vap in Toronto Ventilator Associated Pneumonia Vap in Vancouver Ventilator Associated Pneumonia Vap in Montreal Ventilator Associated Pneumonia Vap in Calgary Ventilator Associated Pneumonia Vap in Edmonton Ventilator Associated Pneumonia Vap in Ottawa Ventilator Associated Pneumonia Vap in Winnipeg Ventilator Associated Pneumonia Vap in Quebec City Ventilator Associated Pneumonia Vap in Hamilton Ventilator Associated Pneumonia Vap in Kitchener Ventilator Associated Pneumonia Vap in London Ventilator Associated Pneumonia Vap in Halifax Ventilator Associated Pneumonia Vap in New York Ventilator Associated Pneumonia Vap in Los Angeles Ventilator Associated Pneumonia Vap in Chicago Ventilator Associated Pneumonia Vap in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease